title: The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells.
abstract: Pituitary adenylate cyclase-activating polypeptide (PACAP) was originally isolated from ovine hypothalamus on the basis of its hypophysiotrophic activity. It has subsequently been shown that PACAP and its receptors are widely distributed in the central nervous system of adult mammals, indicating that PACAP may act as a neurotransmitter and/or neuromodulator. It has also been found that PACAP and its receptors are expressed in germinative neuroepithelia, suggesting that PACAP could be involved in neurogenesis. There is now compelling evidence that PACAP exerts neurotrophic activities in the developing cerebellum and in embryonic stem (ES) cells. In particular, the presence of PACAP receptors has been demonstrated in the granule layer of the immature cerebellar cortex, and PACAP has been shown to promote survival, inhibit migration and activate neurite outgrowth of granule cell precursors. In cerebellar neuroblasts, PACAP is a potent inhibitor of the mitochondrial apoptotic pathway through activation of the MAPkinase extracellular regulated kinase. ES cells and embryoid bodies (EB) also express PACAP receptors and PACAP facilitates neuronal orientation and induces the appearance of an electrophysiological activity. Taken together, the anti-apoptotic and pro-differentiating effects of PACAP characterised in cerebellar neuroblasts as well as ES and EB cells indicate that PACAP acts not only as a neurohormone and a neurotransmitter, but also as a growth factor.
authors.affiliation: INSERM U413, Laboratory of Cellular and Molecular Neuroendocrinology, European Institute for Peptide Research (IFRMP 23), University of Rouen, Mont-Saint-Aignan, France.
authors.forename: A
authors.initials: A
authors.lastname: Falluel-Morel
authors.forename: M
authors.initials: M
authors.lastname: Chafai
authors.forename: D
authors.initials: D
authors.lastname: Vaudry
authors.forename: M
authors.initials: M
authors.lastname: Basille
authors.forename: M
authors.initials: M
authors.lastname: Cazillis
authors.forename: N
authors.initials: N
authors.lastname: Aubert
authors.forename: E
authors.initials: E
authors.lastname: Louiset
authors.forename: S
authors.initials: S
authors.lastname: de Jouffrey
authors.forename: J F
authors.initials: JF
authors.lastname: Le Bigot
authors.forename: A
authors.initials: A
authors.lastname: Fournier
authors.forename: P
authors.initials: P
authors.lastname: Gressens
authors.forename: W
authors.initials: W
authors.lastname: Rostène
authors.forename: H
authors.initials: H
authors.lastname: Vaudry
authors.forename: B J
authors.initials: BJ
authors.lastname: Gonzalez
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D002454:Cell Differentiation / Q000502:physiology*; D002531:Cerebellum / Q000166:cytology* / Q000254:growth & development / Q000502:physiology; D053595:Embryonic Stem Cells / Q000166:cytology* / Q000502:physiology; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D020932:Nerve Growth Factor / Q000502:physiology; D009474:Neurons / Q000166:cytology* / Q000502:physiology; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide / Q000502:physiology*
chemical_list: D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D020932:Nerve Growth Factor